Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping...
Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping...
Steve leaves Lundbeck UK after 14 years where he held a variety of senior commercial roles.
Guyer M.D. is a long standing member of the US retina community and is currently the Co-Founder and Chief Executive...
Hildemann is a board-certifiedInternist and Cardiologist trained in the U.S. and Germany. In his role asCMO, Hildemann...
Kirsty joins from InVentiv Health’s medical education house, Litmus, where she was a member of the leadership team....
ICON Legal Counsel, Diarmaid Cunningham, has also been elected as Secretary of ACRO for a second term.
Soloway joins Ascendis from Transcept Pharmaceuticals where he was a co-founder of the company and served initially as...
Gilham’s healthcare industry career spans thirty years, including a stints as Chief Executive of Axis-Shield and...
Nyenhuis will succeed Curt Welling as President and Chief Executive of AmeriCares on January 27. Nyenhuis is the...
, Kowa Research Europe Ltd. and Kowa Pharmaceuticals Europe Ltd. Boards have appointed Mr. Gilles Picard as President...
As a Senior Scientist, Matt brings to ERT a wealth of first-hand experience in designing, implementing, and leveraging...
He will take up his new position on April 1st, 2014, reporting directly to Christel Bories, Deputy CEO of the Ipsen...
For six years (2002-8) Zinta was Managing Director of the Turkish arm of Boehringer Ingelheim and for the last 12...
Henk was at Plant Genetic Systems for a decade, first as a researcher and then as a business development manager....
Hoefer has gained more than 20 years of international non-clinical development and management experience in academic...